Clinical Trial Update: Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Qinggongshoutao Bolus evaluating efficacy and safety in amnestic mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Qinggongshoutao Bolus

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Mild Cognitive Impairment, Herbal Medicine Allergy | Phase 4 | Status: COMPLETED